BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Leukemia
,
Stem cell
,
Hematopoietic cell
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TRE17
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Muscular dystrophy
Kidney cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CXCR4 Peptide Antagonist LY2510924
Pneumovax
Influenza Vaccines
Culture media, differentiation
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
ZNF804A
GLIPR1
NR4A2
ETV5
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Jak1-STAT3 Signals Are Essential Effectors of the USP6/TRE17 Oncogene in Tumorigenesis.
TRE17/USP6 regulates ubiquitylation and trafficking of cargo proteins that enter cells by clathrin-i…
Atypical mechanism of NF-κB activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and it…
The oncogenic TBC domain protein USP6/TRE17 regulates cell migration and cytokinesis.
TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for TRE17
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ